Finland· FI-REL-REL42988

Nexgard

A afoxolaner product containing afoxolaner, registered in Finland by Boehringer Ingelheim Vetmedica GmbH. The same ATC class is registered in 2 of our 19 countries.

ATC QP53BE01

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedNexgardATCQP53BE01REGISTER NO.FI-REL-REL42988PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Afoxolaner is registered in 2 of 19 countries.

Countries holding a registration under ATC QP53BE01 (afoxolaner), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 1 of them publish a price we can compare per daily dose

Afoxolaner · ATC QP53BE01

2 / 19 countries

  • Denmark
  • Finlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Afoxolaner
Manufacturer
Boehringer Ingelheim Vetmedica GmbH
Country
Finland (FI)
ATC code
QP53BE01
ATC class
Afoxolaner
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Afoxolaner in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All afoxolaner products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e8105324-16c4-420a-a05b-90be04b8d603
GET /v1/drugs/e8105324-16c4-420a-a05b-90be04b8d603?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "purutabletti",
  "route": "Suun kautta",
  "ddd_unit": null,
  "strength": "28.3 mg",
  "atc_label": "Afoxolaner",
  "ma_number": null,
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": "EU/2/13/159/004-006, 014, 018",
  "fimea_rel_id": "REL42988",
  "authorised_at": "2014-02-11"
}

See everything about afoxolaner.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.